Postpartum invasive group A streptococcal disease in the modern era

Infectious Diseases in Obstetrics and Gynecology

Volumn 2008, Issue , 2008, Pages

  Aronoff, David M ^a   Mulla, Zuber D ^b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Paul L Foster School of Medicine   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFAZOLIN; CEFEPIME; CLINDAMYCIN; DOXYCYCLINE FOSFATEX; GENTAMICIN; HYPERTENSIVE FACTOR; METRONIDAZOLE; PENICILLIN G; SULTAMICILLIN; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CASE REPORT; CLINICAL FEATURE; DELIVERY; DEMOGRAPHY; FEMALE; GROUP A STREPTOCOCCAL INFECTION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOTENSION; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PUERPERAL INFECTION; RETROSPECTIVE STUDY; SURVIVAL; TOXIC SHOCK SYNDROME; UNITED STATES; ISOLATION AND PURIFICATION; LENGTH OF STAY; MALE; MICROBIOLOGY; NONPARAMETRIC TEST; PREGNANCY COMPLICATION; PUERPERIUM; RISK FACTOR; STATISTICS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ADULT; ANTI-BACTERIAL AGENTS; FEMALE; FLORIDA; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 58149466835     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/2008/796892     Document Type: Article

References (29)

1. Maharaj D., Puerperal pyrexia: a review. Part I Obstetrical and Gynecological Survey 2007 62 6 393 399
2. Weissmann G., Puerperal priority The Lancet 1997 349 9045 122 125
3. Carapetis J. R., Steer A. C., Mulholland E. K., Weber M., The global burden of group A streptococcal diseases Lancet Infectious Diseases 2005 5 11 685 694
4. Chuang I., Van Beneden C., Beall B., Schuchat A., Population-based surveillance for postpartum invasive group A streptococcus infections, 1995-2000 Clinical Infectious Diseases 2002 35 6 665 670
5. O'Brien K. L., Beall B., Barrett N. L., Epidemiology of invasive group A Streptococcus disease in the United States, 1995-1999 Clinical Infectious Diseases 2002 35 3 268 276
6. Mulla Z. D., Leaverton P. E., Wiersma S. T., Invasive group A streptococcal infections in Florida Southern Medical Journal 2003 96 10 968 973
7. Nuwayhid Z. B., Aronoff D. M., Mulla Z. D., Blunt trauma as a risk factor for group A streptococcal necrotizing fasciitis Annals of Epidemiology 2007 17 11 878 881
8. Schwartz B., Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition The Journal of the American Medical Association 1993 269 3 390 391
9. Mulla Z. D., Invasive group A streptococcal infections in Florida: descriptive epidemiology and risk factors for hospital mortality, Ph.D. dissertation 2001 Tampa, Fla, USA University of South Florida
10. Anteby E. Y., Yagel S., Hanoch J., Shapiro M., Moses A. E., Puerperal and intrapartum group A streptococcal infection Infectious Diseases in Obstetrics and Gynecology 1999 7 6 276 282
11. Harper M., Dugan E., Espeland M., Martinez-Borges A., McQuellon C., Why African-American women are at greater risk for pregnancy-related death Annals of Epidemiology 2007 17 3 180 185
12. Mulla Z. D., Gibbs S. G., Aronoff D. M., Correlates of length of stay, cost of care, and mortality among patients hospitalized for necrotizing fasciitis Epidemiology and Infection 2007 135 5 868 876
13. Births,. Florida Department of Health, Office of Planning, Evaluation and Data Analysis, October 2008, http://www.floridacharts.com/charts/chart.aspx
14. Stevens D. L., Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment Emerging Infectious Diseases 1995 1 3 69 78
15. Wahl R. U., Lütticken R., Stanzel S., van der Linden M., Reinert R. R., Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system Clinical Microbiology and Infection 2007 13 12 1173 1178
16. Sierra J. M., Sánchez F., Castro P., Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003 Medicine 2006 85 3 139 146
17. Young M. H., Engleberg N. C., Mulla Z. D., Aronoff D. M., Therapies for necrotising fasciitis Expert Opinion on Biological Therapy 2006 6 2 155 165
18. Stevens D. L., Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clinical Infectious Diseases 1995 21 4 977 980
19. Mulla Z. D., Nonsteroidal anti-inflammatory drugs and hypotension among patients hospitalized for invasive group A streptococcal disease Annals of Epidemiology 2003 13 7 543 544
20. Aronoff D. M., Bloch K. C., Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus Medicine 2003 82 4 225 235
21. Aronoff D. M., Mulla Z. D., Nonsteroidal antiinflammatory drugs and group A streptococcal infection Emerging Infectious Diseases 2006 12 8 1291
22. Castagnola D. E., Hoffman M. K., Carlson J., Flynn C., Necrotizing cervical and uterine infection in the postpartum period caused by group A streptococcus Obstetrics and Gynecology 2008 111 2, part 2 533 535
23. Silver R. M., Heddleston L. N., McGregor J. A., Gibbs R. S., Life-threatening puerperal infection due to a group A streptococci Obstetrics and Gynecology 1992 79 5, part 2 894 896
24. Group A Streptococcal (GAS) Disease,. Centers for Disease Control and Prevention, October 2008, http://www.cdc.gov/ncidod/dbmd/diseaseinfo/ groupastreptococcal-g.htm#How%20is%20invas%20treated
25. Stevens D. L., Bisno A. L., Chambers H. F., Practice guidelines for the diagnosis and management of skin and soft-tissue infections Clinical Infectious Diseases 2005 41 10 1373 1406
26. Zimbelman J., Palmer A., Todd J., Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection Pediatric Infectious Disease Journal 1999 18 12 1096 1100
27. Russell N. E., Pachorek R. E., Clindamycin in the treatment of streptococcal and staphylococcal toxic shock syndromes The Annals of Pharmacotherapy 2000 34 7 936 939
28. Barry J.-S., Burge J. A., Byles D. B., Morgan M. S., Severe invasive β haemolytic group A streptococcal cellulitis and eyelid necrosis treated with linezolid British Journal of Ophthalmology 2006 90 9 1204
29. Raymond J., Schlegel L., Garnier F., Bouvet A., Molecular characterization of Streptococcus pyogenes isolates to investigate an outbreak of puerperal sepsis Infection Control and Hospital Epidemiology 2005 26 5 455 461